Aptevo Therapeutics (APVO) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-21.09
-14.62
-8.14
-1.67

Details

Expected EPS
-21.09
Actual EPS
-17.76
Surprise EPS
3.33
Surprise Percent
+15.79%

Description

⁨Aptevo Therapeutics⁩ (⁦APVO⁩) has reported earnings of ⁦-17.76⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts